Abstract
Large-scale whole-genome sequencing (WGS) data provides unprecedented opportunity to explore the role of rare variants in non-coding regions on complex traits. However, unlike gene-based exome analysis, non-coding regions lack a well-defined unit for rare-variant testing. Here, we utilized 1,036,913 candidate Cis-Regulatory Elements (cCREs) from ENCODE as analysis units and conducted rare-variant association analysis for 100 traits with SAIGE-GENE+. In a discovery set of 150K White-British samples we identified 1,987 significant associations and replicated 88% of them in a validation set of 250K White-British samples. Associations were enriched in promoter-like signals (PLS) and proximal enhancer- like signals (pELS). Conditional analyses of 230 cCREs across five traits on GWAS variants identified 68 independent cCRE associations. A leukemia case study highlighted key loci, including a PLS for SRSF2 and a pELS for BCL6, demonstrating the effectiveness of cCRE- based analysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Brain Pool Plus (BP+) Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2020H1D3A2A03100666). This research was conducted using the UKBB Resource under application number 45227.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data used is publicly available data published by UK Biobank and accessed on the UK Biobank research platform DNA nexus
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
